Wow. American College of Cardiology no longer recommending diet and exercise for weight loss, going straight to Ozempic.

by


The American College of Cardiology just released new guidance that flips the old playbook. For years, patients were told to try diet and exercise first, then consider medication if that failed. That sequence is now optional.

In its June 2025 clinical guidance, the ACC recommends that doctors can now consider weight loss drugs like Ozempic (semaglutide) and Mounjaro (tirzepatide) as first-line treatments for eligible patients. No more mandatory “try and fail” period with lifestyle changes

https://sciencex.com/wire-news/511880778/american-college-of-cardiology-issues-guidance-on-weight-managem.html

https://www.acc.org/About-ACC/Press-Releases/2025/06/20/14/11/American-College-of-Cardiology-Issues-Guidance-on-Weight-Management-Drugs

https://cardiovascularbusiness.com/topics/clinical/heart-health/american-college-cardiology-now-supports-early-use-medication-treat-obesity

Uh-oh! It looks like you're using an ad blocker.

Our website relies on ads and the generous support of readers like you to keep delivering free, high-quality content. Right now, we are facing serious funding challenges and we need your help more than ever. Disable your ad blocker and this message will vanish. You can also sign up for a membership to enjoy an ad-free experience while supporting our work: https://citizenwatchreport.com/plans/subscriptions/ Your support helps us stay independent, continue our work, and keep content free for everyone. We truly appreciate your understanding and thank you for standing with us.